Oxford Asset Management LLP Acquires 9,443 Shares of CVS Health Co. (NYSE:CVS)

Oxford Asset Management LLP raised its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 110.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 17,999 shares of the pharmacy operator's stock after purchasing an additional 9,443 shares during the period. Oxford Asset Management LLP's holdings in CVS Health were worth $808,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Ridgewood Investments LLC increased its holdings in CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock worth $28,000 after buying an additional 450 shares in the last quarter. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health during the 4th quarter valued at about $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health during the fourth quarter valued at approximately $29,000. Financial Perspectives Inc lifted its position in CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after purchasing an additional 466 shares during the period. Finally, Compass Planning Associates Inc purchased a new stake in CVS Health in the fourth quarter worth approximately $37,000. Institutional investors own 80.66% of the company's stock.

Insider Activity at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by insiders.

CVS Health Price Performance

Shares of CVS stock traded up $0.07 during mid-day trading on Tuesday, hitting $65.00. The company had a trading volume of 9,300,849 shares, compared to its average volume of 11,836,170. The company has a market capitalization of $81.95 billion, a P/E ratio of 17.76, a P/E/G ratio of 0.98 and a beta of 0.57. The stock's 50 day moving average price is $66.45 and its 200-day moving average price is $58.75. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $71.45. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities research analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.09%. CVS Health's dividend payout ratio is currently 72.68%.

Wall Street Analysts Forecast Growth

CVS has been the topic of several research analyst reports. Argus set a $77.00 price target on CVS Health in a report on Tuesday, February 18th. UBS Group lowered their target price on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a report on Tuesday, February 11th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Finally, Mizuho lifted their price target on shares of CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 9th. Four investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $71.83.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.